ANSYS Aktie
WKN: 901492 / ISIN: US03662Q1058
08.01.2025 14:24:34
|
Synopsys Issues Statement In Response To CMA's Provisional Acceptance Of Proposed Remedies
(RTTNews) - Synopsys (SNPS) said the company is very pleased that the CMA has taken the important step of provisionally accepting proposed remedies in Phase 1 regarding proposed acquisition of Ansys (ANSS), rather than referring the transaction to Phase 2. The company continues to expect the transaction to close in the first half of 2025.
"We will maintain our constructive and collaborative engagement with the CMA as it completes its process. Customers continue to express their overwhelming support for the transaction," Synopsys stated.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ANSYS Inc.mehr Nachrichten
Analysen zu ANSYS Inc.mehr Analysen
Aktien in diesem Artikel
ANSYS Inc. | 289,30 | -2,00% |
|
Synopsys Inc. | 400,55 | -2,99% |
|